Dianomi Therapeutics, Inc.
Biotechnology company · Madison, Wisconsin, United States
Dianomi Therapeutics, Inc. is a biotechnology company headquartered in Madison, Wisconsin, United States. Its earliest recorded incorporation is in 2017. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $251,880 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $185,000 sold in a notice filed in 2019.
Dianomi Therapeutics at a glance
What does Dianomi Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $251,880 in total (2020). NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $185,000 sold (2019).
Frequently asked questions about Dianomi Therapeutics
Where is Dianomi Therapeutics headquartered?
Dianomi Therapeutics, Inc. is headquartered in Madison, Wisconsin, United States.
What does Dianomi Therapeutics do?
Dianomi Therapeutics, Inc. is a biotechnology company.
When was Dianomi Therapeutics founded?
The earliest incorporation on record for Dianomi Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Flugen IncMadison, Wisconsin, United States
- Stemina Biomarker Discovery, Inc.Madison, Wisconsin, United States
- BrainXell, Inc.Madison, Wisconsin, United States
- Cellular Logistics, Inc.Madison, Wisconsin, United States
- Capio Biosciences, Inc.Madison, Wisconsin, United States
- Protegera, Inc.Madison, Wisconsin, United States
- Semba Biosciences IncMadison, Wisconsin, United States
- Scarab Genomics LLCMadison, Wisconsin, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences